Skip to Content

Notice

Prospective Grant of Limited Exclusive License: Radioimmunotherapy Utilizing Bismuth 213 and Monoclonal Antibodies Having Binding Specificity to Tag-72 and Human Carcinomas

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.